Brain Congenital myopathy Thérapie génique Calcium Cardiomyopathy Genetics Humans AAV Laminopathie Satellite cell LMNA gene Lamin A/C LMNA gene Myotonic Dystrophy type 1 Satellite cells Autoimmune diseases Lamin A/C Gene therapy Myasthenia gravis ALS Heart failure Skeletal muscle Actin Autoantibodies Mechanotransduction Muscular dystrophy Transgenic mouse model COVID-19 MBNL FSHD Myotonic dystrophy Biomarker Nuclear envelope Becker muscular dystrophy Aging Congenital muscular dystrophy Myositis RNA biology Long read sequencing Myopathies Antisense oligonucleotides Centronuclear myopathy Genotype phenotype correlation CMS Errance diagnostique Myopathy Myotonic Dystrophy DMD Thymus Therapy Dystrophin RNA interference Cell therapy Muscle regeneration Rare diseases Treatment Rare neuromuscular diseases Transcriptomics Neuromuscular junction Glutamate Dynamin 2 Dilated cardiomyopathy Heart Mouse model CRISPRi OPMD Cytoskeleton Alternative splicing Mice Autophagy Cytokines Inflammation Motoneuron Trinucleotide repeat expansion Autoimmunity Laminopathy Neuromuscular diseases Male Dermatomyositis Fibrosis Myasthenia Gravis MG Animals Muscle LMNA CTG repeat contractions Outcome measures Astrocyte Laminopathies PABPN1 Myoblasts Regeneration Duchenne muscular dystrophy Neuromuscular disease Amyotrophic lateral sclerosis Exercise Spinal muscular atrophy Myogenesis Fabry disease Biomarkers Aged Myotonic dystrophy type 1